...
机译:用T-TuCb可溶的环氧化物水解酶抑制减轻了大鼠四氯化碳诱导的肝硬化中的肝纤维化和栅格压力
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Gen Surg Shanghai 201999 Peoples;
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Gen Surg Shanghai 201999 Peoples;
Changzhou Wujin Peoples Hosp Dept Vasc Surg Changzhou Jiangsu Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Gen Surg Shanghai 201999 Peoples;
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Gen Surg Shanghai 201999 Peoples;
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Gen Surg Shanghai 201999 Peoples;
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Gen Surg Shanghai 201999 Peoples;
Hepatic cirrhosis; Portal hypertension; Soluble epoxide hydrolase; Epoxyeicosatrienoic acids;
机译:用T-TuCb可溶的环氧化物水解酶抑制减轻了大鼠四氯化碳诱导的肝硬化中的肝纤维化和栅格压力
机译:可溶性环氧化物水解酶通过保护肝硬化大鼠的肠系膜动脉肌原致抗应答降低了门骨压力
机译:相位对比计算机断层扫描:门骨压力和三维肝脏样品的三维微血管从大鼠四氯化碳诱导的肝纤维化的三维微血管术之间的相关性研究
机译:Flk1间充质干细胞的全身输注可改善四氯化碳诱导的小鼠肝纤维化
机译:地西p和可溶性环氧化物水解酶抑制的组合治疗可阻止癫痫发作并调节TETS中毒小鼠模型的神经炎症反应。
机译:t-TUCB抑制可溶性环氧水解酶的药理作用可改善饮食诱导肥胖症中棕色脂肪组织的活性
机译:T-Tucb可溶的环氧化物水解酶抑制促进棕色脂肪发生,减少饮食诱导肥胖症中的血清甘油三酯